NSE Q2 FY27 Results: Consolidated Profit Rises 23% To ₹2,578 Crore As Total Income Grows 9% Year-on-Year

  • Posted: 03 Nov 2026, 7:47 PM IST
  • 1.5 Min. Read

NSE Q2 FY27 Results: Consolidated Profit Rises 23% To ₹2,578 Crore As Total Income Grows 9% Year-on-Year
NSE reports 23% growth in Q2 FY27 profit as operating EBITDA reaches ₹3,079 crore.

National Stock Exchange of India (NSE) reported a 23% year-on-year (YoY) increase in consolidated profit after tax (PAT) to ₹2,578 crore in Q2 FY27. Consolidated total income rose 9% to ₹4,554 crore, and operating EBITDA more than doubled.

National Stock Exchange of India Limited (NSE) reported a 9% YoY increase in consolidated total income to ₹4,554 crore in Q2 FY27, compared with ₹4,160 crore in the corresponding quarter last year. Consolidated PAT increased 23% to ₹2,578 crore from ₹2,098 crore.

Consolidated operating earnings before interest, tax, depreciation and amortisation (EBITDA) increased 107% YoY to ₹3,079 crore, with an EBITDA margin of 76%.

The NSE share price closed at ₹1803.80 on 03 November, up 1.35% on the Bombay Stock Exchange (BSE).

Revenue from transaction charges increased 9% to ₹3,035 crore as compared with ₹2,789 crore in Q2 FY26.

The cash market recorded an average daily traded volume (ADTV) of ₹1,18,377 crore, up 24% YoY. ADTV in equity options, measured by premium value, increased 3% to ₹47,977 crore. The equity futures segment recorded an ADTV of ₹1,24,574 crore.

Other revenue streams also reported growth. Income from data feed and terminal services rose 43% to ₹165 crore, while listing services revenue increased 70% to ₹150 crore. Operating investment income grew 9% to ₹237 crore. Revenue from data connectivity charges stood at ₹267 crore.

Total expenditure declined 51% to ₹1,161 crore from ₹2,354 crore in Q2 FY26. The year-ago quarter included a provision of ₹1,297 crore towards Securities and Exchange Board of India (SEBI) settlement fees relating to colocation and dark fibre matters. The lower comparative expense base contributed to the sharp increase in operating profitability.

For H1 FY27, consolidated total income increased 9% to ₹9,807 crore from ₹8,959 crore in H1 FY26. Operating EBITDA rose 45% to ₹6,674 crore, with a margin of 77%.

Consolidated net profit increased 13% to ₹5,698 crore. Earnings per share (EPS), on a non-annualised basis, stood at ₹23.02 for the six-month period.

Standalone total income grew 8% to ₹8,568 crore, including operating revenue of ₹7,634 crore. Operating EBITDA increased 51% to ₹5,726 crore, with a margin of 75%. Net profit rose 12% to ₹4,798 crore, with a margin of 56%.

Also Read - Pfizer India Q2 FY27 Results: Revenue Rises 13.2% And Net Profit Jumps 65.7% After ₹132.06 Crore Exceptional Gain

This article is for informational purposes only and should not be considered investment advice from Kotak Neo. For compliance T&C and disclaimers, Visit www.kotakneo.com/disclaimer

About the Author
Vishwa Ved
Vishwa Ved

Vishwa has spent 10+ years across fintech and FMCG doing what most people miss, connecting the dots, catching trends before they trend, and finding the angle nobody else thought to ask about.

At Kotak Neo, she drives content strategy for neoshorts, Kotak News Desk, and Investing Guide, turning market noise into something worth reading.

When she's not decoding markets, she trades charts for canvases, chasing art, painting, and architecture across cities she's yet to explore.